Karex Berhad (KAREX) Stock Overview
An investment holding company, manufactures and sells condoms in Malaysia. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 1/6 |
KAREX Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Top Community Narratives
Karex Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM 0.47 |
| 52 Week High | RM 1.05 |
| 52 Week Low | RM 0.43 |
| Beta | 0.63 |
| 1 Month Change | 7.95% |
| 3 Month Change | -5.00% |
| 1 Year Change | -30.66% |
| 3 Year Change | -8.65% |
| 5 Year Change | 5.56% |
| Change since IPO | -34.57% |
Recent News & Updates
Protected Profits: How the World’s Largest Condom Maker Turned a Global Crisis Into a "Covered" Investment Opportunity
Every so often, an investment story comes along that makes you pause — not because it is complex or obscure, but because it was hiding in plain sight the whole time. This week’s unlikely standout is Karex, a Malaysia-listed company that quite literally makes a product the world cannot afford to run out of — especially now.Karex Berhad (KLSE:KAREX) Has Some Difficulty Using Its Capital Effectively
What underlying fundamental trends can indicate that a company might be in decline? A business that's potentially in...Recent updates
Protected Profits: How the World’s Largest Condom Maker Turned a Global Crisis Into a "Covered" Investment Opportunity
Every so often, an investment story comes along that makes you pause — not because it is complex or obscure, but because it was hiding in plain sight the whole time. This week’s unlikely standout is Karex, a Malaysia-listed company that quite literally makes a product the world cannot afford to run out of — especially now.Karex Berhad (KLSE:KAREX) Has Some Difficulty Using Its Capital Effectively
What underlying fundamental trends can indicate that a company might be in decline? A business that's potentially in...We Think Karex Berhad (KLSE:KAREX) Is Taking Some Risk With Its Debt
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Why Investors Shouldn't Be Surprised By Karex Berhad's (KLSE:KAREX) P/S
When you see that almost half of the companies in the Personal Products industry in Malaysia have price-to-sales ratios...Karex Berhad (KLSE:KAREX) Has Affirmed Its Dividend Of MYR0.005
The board of Karex Berhad ( KLSE:KAREX ) has announced that it will pay a dividend on the 24th of June, with investors...Should You Investigate Karex Berhad (KLSE:KAREX) At RM0.81?
Karex Berhad ( KLSE:KAREX ), might not be a large cap stock, but it saw a significant share price rise of 42% in the...Karex Berhad (KLSE:KAREX) Might Not Be As Mispriced As It Looks
With a price-to-sales (or "P/S") ratio of 1.3x Karex Berhad ( KLSE:KAREX ) may be sending bullish signals at the...Should You Think About Buying Karex Berhad (KLSE:KAREX) Now?
Karex Berhad ( KLSE:KAREX ), is not the largest company out there, but it led the KLSE gainers with a relatively large...Calculating The Intrinsic Value Of Karex Berhad (KLSE:KAREX)
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Karex Berhad...Karex Berhad (KLSE:KAREX) Just Released Its Full-Year Earnings: Here's What Analysts Think
As you might know, Karex Berhad ( KLSE:KAREX ) last week released its latest annual, and things did not turn out so...Shareholder Returns
| KAREX | MY Personal Products | MY Market | |
|---|---|---|---|
| 7D | -3.1% | -0.02% | 0.4% |
| 1Y | -30.7% | -13.4% | 8.9% |
Return vs Industry: KAREX underperformed the MY Personal Products industry which returned -13.4% over the past year.
Return vs Market: KAREX underperformed the MY Market which returned 8.9% over the past year.
Price Volatility
| KAREX volatility | |
|---|---|
| KAREX Average Weekly Movement | 5.1% |
| Personal Products Industry Average Movement | 6.0% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in MY Market | 11.7% |
| 10% least volatile stocks in MY Market | 2.5% |
Stable Share Price: KAREX has not had significant price volatility in the past 3 months compared to the MY market.
Volatility Over Time: KAREX's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | 3,061 | Miah Goh | www.karex.com.my |
Karex Berhad, an investment holding company, manufactures and sells condoms in Malaysia. The company provides personal lubricants; probe covers; and catheters for transurethral drainage of the urinary bladder, as well as gloves. It also offers hand sanitizer and pre-vulcanised latex products.
Karex Berhad Fundamentals Summary
| KAREX fundamental statistics | |
|---|---|
| Market cap | RM 516.20m |
| Earnings (TTM) | -RM 12.96m |
| Revenue (TTM) | RM 482.03m |
Is KAREX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KAREX income statement (TTM) | |
|---|---|
| Revenue | RM 482.03m |
| Cost of Revenue | RM 339.18m |
| Gross Profit | RM 142.85m |
| Other Expenses | RM 155.81m |
| Earnings | -RM 12.96m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.012 |
| Gross Margin | 29.63% |
| Net Profit Margin | -2.69% |
| Debt/Equity Ratio | 38.9% |
How did KAREX perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/08/14 10:20 |
| End of Day Share Price | 2026/08/14 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Karex Berhad is covered by 10 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Aaron Jen Kee | Affin Hwang Investment Bank |
| Lik Hsin Aw | CGS International |
| Megat Fais | Citigroup Inc |